My Medication Side Effects Are Too Popular

"There is also Pfizer's Viagra market, which will also be taken away by your new drugs, so Pfizer will acquire some companies in the east that provide raw materials for medicines.

Enterprises, is to use the scale of capital to suppress you.

"This method is ineffective for us, Johnson & Johnson, because we have a complete industrial chain, and we can also produce basic raw materials for medicines.

"Actually, if you have the funds, you can do it too. As long as you agree to incorporate the new drug, Germinal, into our joint venture.

Edward stated his purpose, and if he could do it, he could directly become a director of Johnson & Johnson.

"It's just some raw materials, it's not that the purchase is not 370, it's just that the price of purchasing from other companies is slightly higher.

Fu Liang shook his head:

By doing this, Pfizer can only slightly slow down the production speed of Xinming Pharmaceutical's new drugs.

What he wants to do to Pfizer is to shake the foundation of Pfizer!

"Dr Edward, I will pay the money, so please do as I ask.

Dr. Edward shrugged: "Okay, you have the final say. But I still think that more cooperation with us, Johnson & Johnson, is also very beneficial to Xinming Pharmaceutical.

"Cooperation between medicines is very common, and many best-selling medicines are jointly launched by multiple companies, and then share the profits.

"In this way, risks can be avoided, and drugs can be promoted faster and better, and more profits can be earned.

Fu Liang still did not let go, Edward felt very sorry, it seemed that it was impossible to make more money.

Old Ran Fu Gaobuyuan actually started more cooperation with Qiangniu.Then, when Xinming Pharmaceutical is difficult to use, there is no reason for Qiangniu to continue to take over.

Although Fu Liangmei and Europe promised deeper cooperation, Johnson & Johnson's clinical work on drugs is still proceeding faster.

The clinical progress of drugs in many countries and regions is very fast, of course, the fastest progress is rapid pain stop.

A week later, Fu Liang heard a pleasant reminder sound coming from his ear.

The system has been upgraded again.

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!

Chapter [-]: God-level new drug for thrombosis!

The system has been upgraded again, this time the magnification of side effects has been increased to 320 times

Fortunately, Johnson & Johnson is more of promoting Supain, which allows Fu Liang to repeatedly gain energy points.

That's why he quickly got more than [-] energy points when the number of clinicians was only over [-].

Fu Liang also took out the prescription for treating pneumonia: "System, enlarge this prescription to prevent platelet aggregation by a factor of [-], and dissolve fibrin.

White side effects one hundred and seventy times.

[The host specifies to amplify the side effects of preventing platelet aggregation by [-] times, and dissolve fibrin by [-] times. Are you sure?]

"Sure!

[The host consumes 32000 energy points, amplifies the side effects of pneumonia medicine to prevent platelet aggregation by [-] times, and dissolves fibrin from the side effects by [-] times.

success. ]

[The fine-tuning formula of the drug has been established, and the side effects of preventing platelet aggregation and fibrinolysis are expected to be ultra-high incidence side effects, and the probability of occurrence

Achieving 99.99%! ]

[Please let the host use the medicine to more people as soon as possible. According to the feedback from the user, a large number of energy points can be obtained. 】

The combination of these two side effects is an effective drug for the prevention and treatment of blood clots!

The thrombus is mainly composed of insoluble fibrin, deposited platelets and blocked red blood cells, self-cells

Thrombosis can cause varicose veins, swelling of lower limbs, difficulty breathing, etc. Severe pulmonary embolism, cerebral thrombosis, etc., can lead to sudden death of a healthy person,

Therefore, many people who have undergone surgery, especially those who have injured the blood vessel wall, will take antithrombotic drugs, because this is a common disease.

It is precisely because of this that the sales of such drugs are so high.

However, there are still many people who have not undergone surgery. It may be due to vascular lesions caused by high blood pressure, high blood sugar, and high blood lipids, which lead to thrombosis.

This is a common disease among the elderly and people with three high

There are many companies producing thrombosis drugs in the world. The leading ones are Pfizer, etc., which can sell billions of dollars every year. Some small pharmaceutical companies,

Can sell for tens of millions of dollars.

Fu Liang didn't think that this drug could make too much money, and it was completely incomparable with painkillers. He just wanted to target Pfizer.

A box of Pfizer's antithrombotic drugs sells for tens of dollars, and the cost of production and sales is actually only a dozen dollars, and the profits are very lucrative.

Fu Gao is going to erode all of Pfizer's drug markets step by step, completely defeating Pfizer.

In order to prevent Pfizer from reacting in advance, when Fu Liang asked Zhou Yongquan to do clinical work this time, he even made a request to the other party.

This time the clinic should be low-key, try not to let people know who developed this drug, and not give Pfizer a chance to prepare.

Wait until the third phase of the clinical trial is over, or after the listing, and then announce it, give Pfizer a head-on attack!

Several directors at Pfizer headquarters sat together with triumphant smiles on their faces

"Williams, your Eastern strategy is progressing very well, Xinming Pharmaceuticals don't even want to launch Germinal on a large scale, they simply don't have enough raw materials.

If you can't go public on a large scale, you can't make a lot of profits quickly, and you can't beat Pfizer's money strategy!

When big companies deal with small companies in their peers, money strategies often work easily.

This is also a warning to some small businesses, telling them not to think that with one or two best-selling drugs, they can compete with Pfizer, at least in a short time.

impossible!

Williams smoked a cigar and spit out a smoke ring: "The impact of the new lung cancer drug from Xinming Pharmaceutical has also been reduced a lot, and the drug that was not on the market.

Also want to get so much attention, do you think they are some big international company?

"According to our investigation, the brand value of Xinming Pharmaceutical has dropped from the previous peak of US$[-] billion to US$[-] billion.

The painkiller from Johnson & Johnson

"If it weren't for that, we could have knocked that Eastern pharma brand down below a billion dollars!

Abel nodded: "Williams, you have contributed to this.

"But also pay attention to whether they have developed any new drugs recently, and don't crash with our best-selling drugs.

Pfizer's stock price has fallen a lot because of several new drugs announced by Xinming Pharmaceutical.

The market value has evaporated more than [-] billion US dollars from the peak of [-] billion US dollars.

Of course, like Pfizer, there are many big pharmaceutical companies whose stock prices have fallen.

On the contrary, the share price of Johnson & Johnson has not risen much, and it has narrowed the gap with Pfizer, and may surpass Pfizer at any time!

The market letter has decreased by more than [-] billion US dollars, how could Pfizer just let it go?

The market value of Xinming Pharmaceutical is only less than [-] billion US dollars, and this is even including those new drugs that have not been listed, and the fixed assets are as high as one billion US dollars!

Abel, do you think they could develop a new drug in such a short time?

Williams shook his head

"The clinical trial of their new drug for treating lung pain is only in Phase II, and other drugs are still in clinical trials around the world.

months to appear in the eastern market.

"Now the valuation of Xinming Pharmaceutical is supported by these prescriptions, and they will definitely focus more on clinical and production approvals.

Eager to develop new drugs?

"Besides, with the scale of Xinming Pharmaceutical, there are too many new drugs, can they promote it?

If Xinming Pharmaceutical continues to cooperate with other pharmaceutical companies, then promotion will of course not be a problem.

However, Xinming Pharmaceutical chose to promote the follow-up drugs by itself, that is, it wanted to swallow such a large piece of cake.

Haven't eaten a piece of cake yet, and made a new one? (Good Zhao good

Besides, if Xinming Pharmaceutical has discovered any new drug targets, it has been publicized long ago. Don't they rely on these to gain popularity now?

Research and development of new drugs also requires costs. He does not believe that Xinming Pharmaceutical can develop a new special drug so quickly!

The other directors of Hui Rui also nodded,

, they agreed with Williams.

However, Abel still reminded Williams not to relax his attention to Xinming Pharmaceutical.

"Okay, I'll be watching over there.

In the next month, Xinming Pharmaceutical did not make any big moves, and Pfizer gradually relaxed its vigilance.

This new drug for the treatment of blood clots has also started Phase II clinical trials.

At this time, Xinming Pharmaceutical finally had good news.

Germinal's approval has come down, and they can produce and sell!

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!.

Chapter [-]: Director Xu Zheng actually has long hair!

After receiving the approval, Shengfaling quickly started production, and within a few days, the first batch of medicines was produced.

All the major provincial drug sales companies in China have gathered in Bingcheng, and the factory of Xinming Pharmaceutical is also constantly delivering goods.

In less than three days, Shengfaling has appeared in the dermatology departments of major hospitals in China.

Many medical cattle do not believe this.

"The clinical time has not exceeded one year? What if the hair loss occurs again after that one year?